Complement-Mediated Glomerular Diseases: A Tale of 3 Pathways

Area of Science:

• Nephrology and Immunology
• Molecular and Cellular Biology

Background:

• The complement system, a crucial part of innate immunity, comprises three distinct activation pathways: classical, lectin, and alternative.
• Recent research highlights the significant involvement of all three complement pathways in the pathogenesis of various glomerular diseases.
• Glomerular lesions, ranging from rare conditions like dense deposit disease to common ones such as IgA nephropathy, are linked to complement activation.

Purpose of the Study:

• To review the fundamental functions of the classical, lectin, and alternative complement pathways.
• To elucidate the mechanisms by which complement activation contributes to glomerular injury in a disease-specific manner.
• To explore the potential of complement-targeted therapies for treating glomerular diseases.

Main Methods:

• Review of existing literature on complement pathways and glomerular diseases.
• Analysis of disease-specific data linking complement activation to glomerular pathology.
• Exploration of preclinical and clinical data on complement-targeted therapeutic strategies.

Main Results:

• All three complement pathways (classical, lectin, alternative) are implicated in the development of glomerular lesions.
• Specific patterns of complement activation correlate with distinct glomerular diseases, including rare and common nephropathies.
• Evidence suggests that dysregulation of complement contributes significantly to kidney damage in these conditions.

Conclusions:

• The complement system is a central player in the pathophysiology of glomerular diseases.
• Targeting specific components or pathways of the complement system offers a promising therapeutic avenue.
• Disease-specific complement inhibition holds potential for effective treatment of glomerular injuries.